CytomX Therapeutics, Inc.
Revenue Breakdown
| Fiscal Year | BMS | Pfizer | AbbVie | Amgen | Astellas | Regeneron | Moderna |
|---|---|---|---|---|---|---|---|
| FY2023 | $4.2M | $0 | $3.3M | $0 | $13.4M | $44.8M | $35.3M |
Revenue Breakdown
| Fiscal Year | BMS | Pfizer | AbbVie | Amgen | Astellas | Regeneron | Moderna |
|---|---|---|---|---|---|---|---|
| FY2023 | $4.2M | $0 | $3.3M | $0 | $13.4M | $44.8M | $35.3M |